In the vaccine development process, what typically occurs in the “Discovery” phase?

Question

BlackTom AI · Accepted Answer

The question asks what typically occurs in the Discovery phase of vaccine development. Here is the analysis of each option with reasoning for and against.

Option 1: 'GMP master-seed development' — Good manufacturing practice (GMP) master-seed development is a step associated with later stages of vaccine development, especially manufacturing scale-up and ensuring quality for production lots. It is not a hallmark activity of the initial Discovery phase, which focuses on understanding the biology and establishing vaccine concepts. Therefore this option is not consistent with Discovery.

Option 2: 'Pathogen identification and host-pathogen interactions study' — This option aligns with the core aim of Discovery: identifying the pathogen of interest and studying how it interacts with the host, including identifying antigens, tropism, virulence factors, and initial targets for a vaccine. This foundational research informs subsequent design and development decisions, making it a typical Discovery activity.

Option 3: 'Regulatory approval' — Regulatory approval is a later-stage milestone that follows preclinical and clinical testing, data compilation, and submission to regulatory agencies. It does not occur during the Discovery phase, and thus this option is incorrect for Discovery.

Option 4: 'Field trials' — Field trials are conducted during later phases of clinical evaluation to assess vaccine effectiveness and safety in real-world populations. They are not part of the Discovery phase, so this option does not describe Discovery activities.

In summary, the Discovery phase is about understanding the pathogen and host interactions to identify viable vaccine targets, while the other options reflect activities associated with later stages of development and testing. The option that best matches that Discovery focus is the one describing pathogen identification and host-pathogen interactions study.

In the vaccine development process, what typically occurs in the “Discovery” phase?Single choice

Similar Questions

A research team is developing a vaccine for a newly discovered virus. However, they find that no known cell lines support replication of the virus. What is the most appropriate conclusion regarding vaccine development?[Fill in the blank]

How familiar are you with the process of vaccine development and approval?

Listen to this introduction to a lecture about the COVID-19 vaccination, and answer the following questions. Question 7 and 8. Choose A, B or C as the best answer. 7. The purpose of the lecture is to explain:

Listen to this introduction to a lecture about the COVID-19 vaccination, and answer the following questions. Question 7 and 8. Choose A, B or C as the best answer. 7. The purpose of the lecture is to explain:

Listen to this introduction to a lecture about the COVID-19 vaccination, and answer the following questions. Question 7 and 8. Choose A, B or C as the best answer. 7. The purpose of the lecture is to explain:

Listen to this introduction to a lecture about the COVID-19 vaccination, and answer the following questions. Question 7 and 8. Choose A, B or C as the best answer. 7. The purpose of the lecture is to explain:

Question 30 Choose a, b, c or d as the best answer. The author’s main argument is that the 100:80:100 model __________.

More Practical Tools for Students Powered by AI Study Helper

Homework AI Solver

Stylized AI Paper Writer

Plagiarism Checker Assistant

Citation AI Academic Writing Tool

In-Class Translation Assistant

AI Note Generator

AI Quiz Answers

Past Exam Questions from University Test Bank

Smart Practice Assistant

Adaptive Practice

Making Your Study Simpler